OrbiMed Advisors ATAI Position
ExitedOrbiMed Advisors exited their position in Atai Beckley N.V. (ATAI) in Q4 2025, after holding the stock for 2 quarters.
The position was first reported in Q3 2025 and has been tracked across 2 quarterly 13F filings.
2 other tracked funds also hold ATAI.
About Atai Beckley N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.
Full company profile →Short Interest
5.7%
3.3 days to cover
OrbiMed Advisors ATAI Position History
Frequently Asked Questions
Does OrbiMed Advisors own ATAI?
No. OrbiMed Advisors exited their position in Atai Beckley N.V. (ATAI) in Q4 2025. They previously held the stock for 2 quarters.
How many hedge funds own ATAI?
2 specialist biotech hedge funds currently hold ATAI, including Deep Track Capital, RTW Investments. When 3 or more specialist funds hold the same stock, BiotechEdge flags it as a convergence signal.
When did OrbiMed Advisors first buy ATAI?
OrbiMed Advisors's position in ATAI was first reported in Q3 2025. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is OrbiMed Advisors's ATAI position increasing or decreasing?
OrbiMed Advisors completely exited their ATAI position in the most recent quarter.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
ATAICompany Page →
All fund holders, insider trades, catalysts, and cash runway
OrbiMed AdvisorsPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →